Journey Medical Corporation DERM Qbrexza — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Journey Medical Corporation in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Journey Medical Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Journey Medical Corporation's qbrexza — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Journey Medical Corporation's qbrexza — revenue?
- Journey Medical Corporation (DERM) reported qbrexza — revenue of $5.03M in Q1 2026.
- How has Journey Medical Corporation's qbrexza — revenue changed year-over-year?
- Journey Medical Corporation's qbrexza — revenue decreased by 2.6% year-over-year, from $5.16M to $5.03M.
- What is the long-term trend for Journey Medical Corporation's qbrexza — revenue?
- Over 2 years (2023 to 2025), Journey Medical Corporation's qbrexza — revenue has grown at a -0.8% compound annual growth rate (CAGR), from $25.41M to $25.02M.
- What does qbrexza — revenue mean?
- Measures the total gross revenue generated from the sale of a specific product, excluding any sales-based taxes collected on behalf of government authorities. This figure serves as the primary indicator of the product's market demand and commercial performance.